Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.US-based biotechnology firm Moderna has partnered with European pharmaceutical company Laboratorios Farmacéuticos Rovi (ROVI) for finish-fill manufacturing of its Covid-19 vaccine candidate, mRNA-1273.
As part of the deal, ROVI will be responsible for large-scale, commercial fill-finish manufacturing of the vaccine product at its facility in Madrid, Spain.
The company will provide vial filling and packaging capacity via a new production line and equipment to carry out compounding, filling, automatic visual inspection and labelling.